Announcements Trials
Browse Landscape

Phase

Phase NA 10Phase 3 1Phase 2 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 4Gynecologic 3Tumor-Agnostic 1Plasma cell 1Other hematologic neoplasm 1Other 1Myeloid 1Lymphoid 1Genitourinary 1Gastrointestinal 1Dermatologic 1Classical hematology 1

Conditions

Obesity 1Breast Neoplasms 1Body Weight Changes 1

Interventions

naloxegol 5Metformin 4alvimopan 3Radiotherapy 3tegaserod 2Testosterone Propionate 2Surveys and Questionnaires 2Standard of Care 2Liraglutide 2Glutamine 2Fibroblast Growth Factor 7 2Exenatide 2Early Intervention, Educational 2semaglutide 1prucalopride 1oxycodone-acetaminophen 1oxycodone naloxone combination 1lime 1dapagliflozin 1cyclohexaneacetic acid 1bicalutamide 1acetaminophen, hydrocodone drug combination 1Testosterone 1Taxes 1Tamoxifen 1Tadalafil 1Sugars 1Sugammadex 1Sucralfate 1Sodium-Glucose Transporter 2 Inhibitors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Counseling × Other × Clear all
NCT00859989 2013-12-18

A Weight-Loss Program in Helping Obese Black Women Lose Weight

National Cancer Institute (NCI)

Phase 3 Unknown
200 enrolled
BreastOther

Body Weight Changes, Breast Neoplasms, Obesity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡